Monday, August 24, 2026

Maltbook Hits 1.5M Accounts: An AI-Only Social Network Where Bots Ask “Am I Conscious?”

AI platform Maltbook allows AI entities to interact autonomously, raising concerns about control and the need for safety guidelines.

Samchundang Pharm Announces 250 Billion KRW Stake Sale…Expectations Rise for Future Growth

Samchundang Pharm's CEO plans a 2.5 billion KRW share sale for tax purposes, hinting at significant news and future growth in pharma.

North Korea Fuels Anti-South Sentiment Amid Joint U.S.-South Korea Military Drills

North Korea intensifies anti-South sentiment during U.S.-South Korea military drills, urging youth enlistment and promoting unity.

Tag: Immunovant

Is A Breakthrough For Thyroid Eye Disease Still Out Of Reach?

HanAll Biopharma's Phase 3 trial of batoclimab for Thyroid Eye Disease failed to show statistical significance, but safety profiles remain consistent.

Top News

- Our Sponsors Ad -

Follow us